Symbol: |
C17orf58
|
Description: |
chromosome 17 open reading frame 58 [Source:HGNC Symbol;Acc:27568]
|
Location: |
Chr17:65987217-65989765[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:184
Gene |
Compound |
Gen_sig |
Exp_pattern |
C17orf58 |
S-(dimethylarsino)-3-mercapto-1,2-propyl dibenzoate |
0.005 |
Down |
C17orf58 |
(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.04,13.08,13]hexadecane |
0.004 |
Down |
C17orf58 |
ARTEMISININ DIMER HEMISUCCINATE |
0.018 |
Down |
C17orf58 |
6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride |
0.022 |
Down |
C17orf58 |
Everolimus |
0.026 |
Up |
C17orf58 |
NSC 734631 |
0.018 |
Down |
C17orf58 |
6-(3-Bromopropyl)-5,6-dihydro-9-methyl-3-nitro-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline |
0.033 |
Down |
C17orf58 |
4-[(Z)-2-(5-nitro-2-furyl)ethenyl]-6-(4-phenylpiperazin-1-yl )-1,3,5-triazin-2-ylamine |
0.011 |
Down |
C17orf58 |
NSC 736189 |
0.014 |
Down |
C17orf58 |
6-(3-Aminopropyl)-5,6-dihydro-3-nitro-5,11-dioxo-9-thiomethy l-11H-indeno[1,2-c]isoquinoline Hydrochloride |
0.043 |
Down |
C17orf58 |
6-(3-Aminopropyl)-9-ethoxy-5,6-dihydro-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride |
0.022 |
Down |
C17orf58 |
NSC 741942 |
0.004 |
Down |
C17orf58 |
NSC 742162 |
0.014 |
Up |
C17orf58 |
3-(5-Benzo[b]thiophen-3-yl-1H-indol-3-yl)-acrylic acid ethyl ester |
0.024 |
Down |
C17orf58 |
NSC 746316 |
0.048 |
Down |
Expression pattern: Sensitivity / Resistance
Total:13 Current:12
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:48
Total:4 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:31
Total:3 Current:1
[First] [Prev]  Next Last 
|